Position in ZTS
as of Mar 31, 2026
· filed May 4, 2026
Position Value
$318,575
+$71,591 QoQ
Shares Held
2,695
+37.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Procyon Advisors, LLC holds $1,263,085 across 5 Drug Manufacturers - Specialty & Generic names.
All Filings in ZTS
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $318,575 | 2,695 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $246,984 | 1,963 | Shares | Sole | 2026-01-07 | |
| 2025-09-30 | $380,724 | 2,602 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $351,355 | 2,253 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $749,486 | 4,552 | Shares | Sole | 2025-04-11 | |
| 2024-12-31 | $767,726 | 4,712 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $908,321 | 4,649 | Shares | Sole | 2024-10-11 | |
| 2024-06-30 | $822,766 | 4,746 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $917,625 | 5,423 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $890,533 | 4,512 | Shares | Sole | 2024-01-18 | |
| 2023-09-30 | $759,770 | 4,367 | Shares | Sole | 2023-10-10 | |
| 2023-06-30 | $259,176 | 1,505 | Shares | Sole | 2023-07-17 | |
| 2020-06-30 | $49,334 | 360 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $38,602 | 328 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||